New test for the detection of synovial sarcoma

ProPath has announced the addition of SS18-SSX to its antibody library. It is a fusion-specific antibody that is highly sensitive (95%) and specific (100%) for the detection of synovial sarcoma.

Synovial sarcoma is a rare form of cancer found in different types of soft tissue, such as muscle or ligaments. It’s often seen in the arm, leg, or foot, and near joints such as the wrist or ankle. It can also form in the lung or abdomen. The SS18-SSX test from ProPath will help clinicians identify if their patient has synovial sarcoma.

More information about ProPath’s IHC laboratory is available online.

www.ProPath.com

Upcoming Events

Hands-free, safe and remote dissection: a Menarini webinar

Online
4 March 2021

COVID-19 - The Infection Challenging the World

Online
11-14 May 2021

Lab Innovations 2021

NEC, Birmingham
3-4 November 2021

IBMS Biomedical Science Congress 2022

International Convention Centre, Birmingham
14-17 March 2022

Upcoming Events

Hands-free, safe and remote dissection: a Menarini webinar

Online
4 March 2021

COVID-19 - The Infection Challenging the World

Online
11-14 May 2021

Lab Innovations 2021

NEC, Birmingham
3-4 November 2021

IBMS Biomedical Science Congress 2022

International Convention Centre, Birmingham
14-17 March 2022